Trial Of Cold MD Ingredients Fails To Substantiate Efficacy Claims – NAD
This article was originally published in The Tan Sheet
Executive Summary
Iovate Health Sciences "strongly disagrees" with the National Advertising Division's recommendation to discontinue some product claims for its Cold MD dietary supplement, but said it will comply with the Council of Better Business Bureaus unit's April 20 decision
You may also be interested in...
Proposed Cold MD settlement
Iomedix Cold International agrees to make refunds to consumers who bought the Cold MD dietary supplement between March 26, 2004, and May 29, 2009. Consumers could receive $5 to $10 per bottle that they purchased as part of a proposed class action settlement. The settlement would resolve allegations the Mississauga, Ontario-based firm made false claims about Cold MD, according to a July 7 press release. The National Advertising Division previously ruled Iovate failed to substantiate efficacy claims (1"The Tan Sheet" April 30, 2007)
Proposed Cold MD settlement
Iomedix Cold International agrees to make refunds to consumers who bought the Cold MD dietary supplement between March 26, 2004, and May 29, 2009. Consumers could receive $5 to $10 per bottle that they purchased as part of a proposed class action settlement. The settlement would resolve allegations the Mississauga, Ontario-based firm made false claims about Cold MD, according to a July 7 press release. The National Advertising Division previously ruled Iovate failed to substantiate efficacy claims (1"The Tan Sheet" April 30, 2007)
Proposed Cold MD settlement
Iomedix Cold International agrees to make refunds to consumers who bought the Cold MD dietary supplement between March 26, 2004, and May 29, 2009. Consumers could receive $5 to $10 per bottle that they purchased as part of a proposed class action settlement. The settlement would resolve allegations the Mississauga, Ontario-based firm made false claims about Cold MD, according to a July 7 press release. The National Advertising Division previously ruled Iovate failed to substantiate efficacy claims (1"The Tan Sheet" April 30, 2007)